Consistently, we have illustrated that MycN knockdown in human NCSCs increased the expression of Cdkn1a, Cdkn2a and Cdkn2b (Fig 4A & 4B), emphasizing the critical role of these tumor suppressors in stem cell growth and cell cycle progression. The gene discussed is MYCN; the disease is neoplasm.